Recorded fact · drug.label_indication
drug.label_indication for ticagrelor|coronary-artery-disease
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 01391240 resolves to.
The record
| Fact id | 01391240140037a38a875d44 |
|---|---|
| Entity | drug: ticagrelor|coronary-artery-disease |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260530 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
Coronary Artery Disease but No Prior Stroke or Myocardial Infarction Ticagrelor tablets are indicated to reduce the risk of a first MI or stroke in patients with coronary artery disease (CAD) at high
Shown with dashes as hyphens. SHA-256 of the exact stored quote: d5fe47f07888fcc0fddeaeea4767218cb016177bc71210e4fc3a84aa1d2c32ac.
The value
{
"ingredient": "Ticagrelor",
"conditionId": "coronary-artery-disease",
"conditionName": "Coronary artery disease",
"matchedAlias": "Coronary Artery Disease",
"context": "indication",
"brand": "Ticagrelor",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "1225fd45-9b56-1671-ee77-cd0c9f2174a5",
"labelEffectiveTime": "20260530",
"labelsRead": 25,
"labelsNaming": 24,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: ba74d4300c17c8bd3c3d9920440013ad456cd17cebb99f4ae8cac4a8eb62c28a.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.